Lv5
1330 积分 2020-06-07 加入
Efficacy and safety benefits of HR17031 , a fixed‐ratio combination of INS068 and noiiglutide, versus its components alone in Chinese patients with type 2 diabetes uncontrolled on oral antidiabetic drug(s): A phase 2, multicentre, open‐label, randomised, parallel three‐arm, treat‐to‐target trial
12天前
已完结
The Conundrum of Pain Intensity and Pain Relief
13天前
已关闭
Optimizing Diagnosis and Management of Dry Eye Disease: A Practical Framework for Hong Kong
14天前
已完结
Inference and missing data
1个月前
已完结
Single cell-resolved transcriptional dynamics of human subcutaneous adipose tissue during lifestyle- and bariatric surgery-induced weight loss
1个月前
已完结
Pharmacokinetics and safety of HR17031, a fixed‐ratio of INS068/Noiiglutide combination, in Chinese patients with hepatic impairment
1个月前
已完结
Proportional-Assist Ventilation for Minimizing the Duration of Mechanical Ventilation
1个月前
已完结
Implications of the European Association for the Study of Obesity’s New Framework Definition of Obesity: Prevalence and Association With All-Cause Mortality
1个月前
已完结
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
1个月前
已完结
When less is more—reducing complexity in cancer trials
1个月前
已完结
皖公网安备34019202002308
